Technology | Breast Imaging | January 25, 2017

HealthDecision LLC Launches Personalized Breast Cancer Screening Software Tool

Software embedded within electronic health records looks at patient’s healthcare data and history to calculate individual risk for developing breast cancer in the next decade

HealthDecision, Breast Cancer Screening tool, personalized risk, UW Health, launch

January 25, 2017 — HealthDecision LLC recently announced the launch of the Breast Cancer Screening tool. This tool provides patients a personalized risk analysis for developing breast cancer in the next 10 years and the benefits or harms associated with mammogram screening.

The tool was tested and currently is used within University of Wisconsin (UW) Health, a healthcare system in the upper Midwest serving 600,000 patients each year with 1,400 physicians and 16,500 staff at six hospitals and 80 outpatient sites.

The Breast Cancer Screening tool is the result of a 2013 WI Partnership Program grant received by the UW Madison Department of Radiology and a joint effort with HealthDecision LLC to create a shared decision-making (SDM) tool that could be used at a routine appointment within a doctor's office. The project grew out of the controversy and confusion about breast cancer screening, and its multidisciplinary team included members from surgery, engineering, psychology, communications, primary care, vascular surgery research and decision making.

HealthDecision is unique in that it is embedded within the electronic health record (EHR) system and considers the patient's healthcare data and history to calculate personalized risk. Risks associated with mammogram screening include over-detection and the subsequent effects of anxiety; possible overtreatment with surgery, radiotherapy and sometimes chemotherapy; cost; and additional impacts on quality of life.

"Healthcare guidelines can be confusing to patients as well as doctors, especially when there is conflicting information in the public domain," said Sarina Schrager, M.D., UW Health and professor in the University of Wisconsin Department of Family Medicine and Community Health. Along with Beth Burnside, M.D., UW Health, who was the principle investigator on the grant, Schrager was heavily involved in the development of the tool, educating other primary care clinicians and driving the implementation strategy within UW Health primary care. "HealthDecision aids my conversation with the patient to better educate and explain the harms and benefits of a mammogram and its possible outcomes. The visualized risk analysis has been key for patients to better understand their personalized risk and increases their confidence to make better informed healthcare decisions for themselves."

The Breast Cancer Screening tool joins a suite of three other HealthDecision shared decision-making tools that provide a patient's personalized risk for the various healthcare options available:

  • The Atrial Fibrillation tool demonstrates a patient's risk of stroke or bleeding from anticoagulant medications;
  • The Cardiovascular Risk tool evaluates a patient's cholesterol and their risk of various statin medications and smoking cessation; and
  • The Lung Cancer Screening tool considers the risk for chest computed tomography (CT) scans for patients who smoke or have smoked.

For more information: www.healthdecision.org

Related Content

MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
Combined Optical and Molecular Imaging Could Guide Breast-Conserving Surgery

WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK

News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.

ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.

News | Breast Imaging | June 12, 2017
ABS, one of the largest breast departments in the country, first signed with Insignia in 2010, and have confirmed a...
mammogram

Photo courtesy of Barco

News | Mammography | June 08, 2017
An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are...
OCM images

These are sample OCM images (first row) and corresponding histology images (second row) of human breast tissue. The ground truth labels for the tissue type of these images are: (a) carcinoma, (b) lobule, (c) stroma, (d) adipose. Image courtesy of Sunhua Wan, Hsiang-Chieh Lee, Xiaolei Huang, Ting Xu, Tao Xu, Xianxu Zeng, Zhan Zhang, Yuri Sheikine, James L. Connolly, James G. Fujimoto, Chao Zhou

News | Clinical Study | June 07, 2017
According to a recent study, one in four women with breast cancer who opt for a breast-saving lumpectomy will need a...
Feature | Women's Health | June 06, 2017 | By David A. Strahle, M.D.
Editor’s note: In this article, David A. Strahle, M.D., candidly shares how and why he and his team became involved...
breast tomosynthesis
News | Breast Imaging | June 06, 2017
Researchers at two leading U.S. breast centers recently completed a study which explored whether women attending...
concurrent-read cancer detection solution for digital breast tomosynthesis
News | Women's Health | June 06, 2017
Carolina Breast Imaging Specialists of Greenville, North Carolina today announced it is the first U.S. site to begin...
Siemens Healthineers and Fraunhofer MEVIS Announce Research Alliance on Clinical Decision Support
News | Clinical Decision Support | May 31, 2017
Siemens Healthineers and the Fraunhofer Institute for Medical Image Computing MEVIS announced the formation of a new...
Kubtec Granted Additional Patent for Breast Specimen Imaging Using 3-D Tomosynthesis
News | Breast Imaging | May 30, 2017
Kubtec announced recently that the U.S. Patent Office has granted the company an additional patent for its technology...
Overlay Init